Company / Tangible Book Value per Share
Amylyx Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.78
FY2025
5-year range
-$22.95 / $48.52
FY2021-FY2025
Trend
+15.7%
vs FY2024
Sector context
#130 of 209
Health Care
What the data says
At $2.78, Amylyx Pharmaceuticals, Inc.'s tangible book value per share ranks #130 of 209 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 2 years of decline, reaching $2.78.
Based on SEC 10-K filings.
2.78 in FY2025 with a 3-year CAGR of -61.5%.
Declined from $6.40 to $2.78 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -61.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 209 in Health CareTop 62% of 209This company $2.78 Sector average $93.47
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 15.7% year-over-year.
- Ranks #130 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.78 | +15.7% |
| FY2024 | $2.40 | -62.5% |
| FY2023 | $6.40 | -86.8% |
| FY2022 | $48.52 | +311.4% |
| FY2021 | -$22.95 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026